Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-18 4:30 pm Unchanged | 2025-02-10 | 13G | Biodexa Pharmaceuticals Plc BDRX | C/M Capital Master Fund, LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-20 11:56 am Purchase | 2024-11-14 | 13G | Biodexa Pharmaceuticals Plc BDRX | Brio Capital Master Fund Ltd. | 167,681 0.900% | 110,567 (+193.59%) | Filing History |
| 2024-11-14 5:12 pm Sale | 2024-09-30 | 13G | Biodexa Pharmaceuticals Plc BDRX | Iroquois Capital Management, LLC | 112,077 0.670% | -44,718,963 (-99.75%) | Filing History |
| 2024-11-12 4:30 pm Purchase | 2024-09-30 | 13G | Biodexa Pharmaceuticals Plc BDRX | Bigger Capital LLC | 69,260,800 11.000% | 59,595,424 (+616.59%) | Filing History |
| 2024-11-07 4:51 pm Sale | 2024-09-30 | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 0 0.000% | -4,647,807 (Position Closed) | Filing History |
| 2024-08-08 4:24 pm Purchase | 2024-07-19 | 13G | Biodexa Pharmaceuticals Plc BDRX | Iroquois Capital Management, LLC | 44,831,040 9.990% | 44,831,040 (New Position) | Filing History |
| 2024-07-23 3:09 pm Purchase | 2024-07-15 | 13G | Biodexa Pharmaceuticals Plc BDRX | Brio Capital Master Fund Ltd. | 57,114 9.830% | 57,114 (New Position) | Filing History |
| 2024-02-14 8:47 pm Purchase | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | Ionic Ventures LLC | 5,421 4.900% | 5,421 (New Position) | Filing History |
| 2024-02-14 2:42 pm Purchase | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | Armistice Capital, LLC | 998 0.940% | 998 (New Position) | Filing History |
| 2024-02-14 2:14 pm Unchanged | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | CVI Investments, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-13 4:33 pm Purchase | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 4,647,807 9.900% | 225,487 (+5.10%) | Filing History |
| 2024-02-12 4:30 pm Purchase | 2023-12-21 | 13G | Biodexa Pharmaceuticals Plc BDRX | Bigger Capital LLC | 9,665,376 9.900% | 9,665,376 (New Position) | Filing History |
| 2024-01-08 4:01 pm Purchase | 2023-12-21 | 13G | Biodexa Pharmaceuticals Plc BDRX | Mercer Street Global Opportunity Fund LLC | 4,375,872 9.990% | 4,375,872 (New Position) | Filing History |
| 2023-12-28 4:30 pm Purchase | 2023-12-21 | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 4,422,320 9.900% | 4,422,320 (New Position) | Filing History |
| 2023-03-06 06:01 am Purchase | 2023-02-15 | 13G | Midatech Pharma plc MTP | Ionic Ventures LLC | 4,509,231 9.990% | 4,509,231 (New Position) | Filing History |
| 2023-02-21 11:10 am Purchase | 2023-02-09 | 13G | Midatech Pharma plc MTP | CVI Investments, Inc. | 2,708,500 6.200% | 2,708,500 (New Position) | Filing History |
| 2023-02-14 1:50 pm Purchase | 2022-12-31 | 13G | Midatech Pharma plc MTP | Armistice Capital, LLC | 96,707 8.930% | 96,707 (New Position) | Filing History |
| 2020-07-10 10:48 am Sale | 2020-06-30 | 13G | Biodexa Pharmaceuticals Plc BDRX | BlackRock Inc. BLK | 23 1.900% | -74 (-76.44%) | Filing |
| 2020-06-09 4:52 pm Sale | 2020-05-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | BlackRock Inc. BLK | 97 9.900% | -1,871 (-95.06%) | Filing |